Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 2 boards, counting each seat separately. Longest: Zenas BioPharma Inc., 2 years.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Addex Therapeutics Ltd | Sold back to the company | −219,561 | — | — |
| Sep 2, 2026 | Addex Therapeutics Ltd | Grant or award | +219,561 | — | — |
| Oct 9, 2025 | Zenas BioPharma Inc. | Open-market purchase | +63,158 | $19.00 | $1,200,002 |
| Sep 16, 2024 | Zenas BioPharma Inc. | Derivative conversion | +1,505,388 | — | — |
| Sep 16, 2024 | Zenas BioPharma Inc. | Open-market purchase | +441,176 | $17.00 | $7,499,992 |
| Sep 16, 2024 | Zenas BioPharma Inc. | Derivative conversion | +669,061 | — | — |
| Sep 16, 2024 | Zenas BioPharma Inc. | Open-market purchase | +441,176 | $17.00 | $7,499,992 |
Questions about Jason Raleigh Nunn
What boards is Jason Raleigh Nunn on?
Jason Raleigh Nunn sits on the boards of Addex Therapeutics Ltd and Zenas BioPharma Inc.
How long has Jason Raleigh Nunn served on boards?
Our records show at least 3 years of board service across 2 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.